Cargando…
Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
Receptor-interacting protein (RIP) kinase 1 is involved in immune-mediated inflammatory diseases including ulcerative colitis (UC) by regulating necroptosis and inflammation. Our group previously identified TAK-632 (5) as an effective necroptosis inhibitor by dual-targeting RIP1 and RIP3. In this st...
Autores principales: | Zhu, Jing, Xin, Meng, Xu, Congcong, He, Yuan, Zhang, Wannian, Wang, Zhibin, Zhuang, Chunlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546889/ https://www.ncbi.nlm.nih.gov/pubmed/34729309 http://dx.doi.org/10.1016/j.apsb.2021.05.017 |
Ejemplares similares
-
Methodology of drug screening and target identification for new necroptosis inhibitors
por: Pan, Pengchao, et al.
Publicado: (2019) -
ABIN1 Inhibits Inflammation through Necroptosis-Dependent Pathway in Ulcerative Colitis
por: Bao, Jing, et al.
Publicado: (2022) -
Emission Tuning of Fluorescent
Kinase Inhibitors:
Conjugation Length and Substituent Effects
por: Dhuguru, Jyothi, et al.
Publicado: (2014) -
Curcumin alleviates experimental colitis in mice by suppressing necroptosis of intestinal epithelial cells
por: Zhong, Yuting, et al.
Publicado: (2023) -
Effect of Narrow Spectrum Versus Selective Kinase Inhibitors on the Intestinal Proinflammatory Immune Response in Ulcerative Colitis
por: Biancheri, Paolo, et al.
Publicado: (2016)